155 results
8-K
EX-10.1
NVTAQ
Invitae Corp
14 Feb 24
Entry into a Material Definitive Agreement
6:59am
Reimbursement Agreements” has the meaning set forth in Section 2(e).
“Parties” has the meaning set forth in the preamble to this Agreement.
“Permitted … ) in connection with any potential transaction
involving the Debtors’ capital structure or a sale of assets (the “Non-Party Reimbursement Agreements
8-K
EX-99.1
NVTAQ
Invitae Corp
8 Nov 23
Invitae Reports Third Quarter 2023 Financial Results
4:05pm
not obtain or maintain sufficient levels of reimbursement for its tests; the applicability of clinical results to actual outcomes; risks associated
424B2
NVTAQ
Invitae Corp
10 Aug 23
Prospectus for primary offering
4:03pm
in reimbursement by current or potential payers;
general economic and market conditions; and
issuances of significant amounts of our common stock
424B2
NVTAQ
Invitae Corp
10 Aug 23
Prospectus for primary offering
4:01pm
of reimbursement for our tests; laws and regulations applicable to our business, including potential regulation by the Food and Drug Administration … ; the risk that Medicare and other payers may change the pricing or other terms for reimbursement, or not reimburse for our tests in the future, or fail
POS AM
smwnnkwb7fh639cxz6oo
9 Aug 23
Prospectus update (post-effective amendment)
9:22am
POS AM
npel9lxwjdi3jh
9 Aug 23
Prospectus update (post-effective amendment)
9:20am
8-K
EX-99.1
6a2pc
8 Aug 23
Invitae Reports Second Quarter 2023 Financial Results
4:09pm
8-K
EX-10.1
6epd1ld rm1hn0s9j
5 Jul 23
Departure of Directors or Certain Officers
4:53pm
8-K
iu21a43d
5 Jul 23
Departure of Directors or Certain Officers
4:53pm
8-K
EX-99.1
3p4n3quau n5t67ib
9 May 23
Invitae Reports First Quarter 2023 Financial Results
4:11pm
424B3
b5llnmq0seyxg
24 Apr 23
Prospectus supplement
4:02pm
8-K
EX-99.1
ndalrf2 bvhhqz
20 Dec 22
Other Events
9:00am
8-K
EX-99.1
5a19z2ql
8 Nov 22
Invitae Reports Third Quarter 2022 Financial Results
4:20pm